If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

  • This share is currently suspended. It was suspended at a price of 305.00
  • There is currently no data for TET

Trading Update

5 Apr 2019 07:00

RNS Number : 2073V
Treatt PLC
05 April 2019
 

 

 

5 April 2019

 

TREATT PLC

("Treatt" or "the Group")

 

Trading Update for the half year ended 31 March 2019

 

Treatt, the manufacturer and supplier of innovative ingredient solutions for the flavour, fragrance, beverage and consumer product industries today publishes a trading update for the half year ended 31 March 2019 (the "Period").

 

The Board is pleased to confirm that following six consecutive years of growth, the business has continued to perform well in the current financial year with revenue for the Period up by approximately 7% compared with the same period in the prior year (5% in constant currency). The growth in the Period was particularly pleasing against a market backdrop of price weakness in some key raw materials for our largest product category, citrus, which we expect to continue into the second half of the current financial year.

 

Whilst citrus continues to dominate our category mix, the fruit and vegetables, tea and sugar reduction categories are also driving revenues, representing 69% of the year-on-year growth for the Period. The vast majority of Treatt's portfolio is targeted at the growing demand from consumers for more natural and clean-label products which is feeding both into our results for the Period as well as our encouraging opportunity pipeline.

 

A key element of the Group's current five-year strategy through to 2022 is to invest in the Group's capacity and scientific capabilities in order to deliver long term growth and value for shareholders. We are, therefore, pleased to confirm that the $14m expansion of our US facility was completed in March 2019 and will become fully operational in June this year. This project has been managed whilst continuing to deliver the excellent product quality and service our global client base has come to expect, without disruption. In the UK, construction of our £35m relocation project is expected to commence this summer, and occupancy to begin in summer 2020.

 

Whilst the Group has in place a hedging strategy to try to ensure that the impact of exchange rate movements is broadly neutral to the income statement over the course of a financial year, as has been experienced previously, there can be material effects over shorter periods of time. During the Period there was a weakening in the USD/GBP exchange rate and, as a result, the Board anticipates a net negative FX impact on the results for the Period of approximately £0.6m.

 

Outlook

We are encouraged by our order book which is comfortably up compared with the same time in the prior year, notwithstanding the weakness in some key citrus raw material input prices. This reflects the success of our continued strategic focus on key product categories and geographical markets and the Board, therefore, continues to believe that profit before tax and exceptional items will be in line with its expectations for the financial year ending 30 September 2019.

 

The Board expects to announce Treatt's half year results for the six months ended 31 March 2019 on 7 May 2019.

 

 

 

 

Enquiries:

 

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Broker

Investec Investment Banking

Patrick Robb +44 (0)20 7597 5970

David Anderson

Alex Wright

 

Public relations

DRD Partnership

Lawrence Dore +44 (0)20 3951 0349

 

About the Group

Treatt is a global, independent supplier of innovative ingredient solutions for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America, Africa and Asia and has manufacturing facilities in the UK, USA and Kenya. Its international foot print enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

 

For further information about the Group, visit www.treatt.com.

 

 

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBLGDSRBGBGCS
Date   Source Headline
3rd Dec 201812:06 pmRNSBlock Listing Six Monthly Return
27th Nov 20187:00 amRNSFinal Results
16th Nov 201812:07 pmRNSSecond Price Monitoring Extn
16th Nov 201812:02 pmRNSPrice Monitoring Extension
14th Nov 201812:13 pmRNSHolding(s) in Company
13th Nov 20184:35 pmRNSPrice Monitoring Extension
9th Nov 20184:40 pmRNSSecond Price Monitoring Extn
9th Nov 20184:35 pmRNSPrice Monitoring Extension
6th Nov 20183:44 pmRNSHolding(s) in Company
16th Oct 20189:30 amRNSBoard Change
12th Oct 201812:07 pmRNSSecond Price Monitoring Extn
12th Oct 201812:02 pmRNSPrice Monitoring Extension
10th Oct 201812:07 pmRNSSecond Price Monitoring Extn
10th Oct 201812:02 pmRNSPrice Monitoring Extension
8th Oct 201812:07 pmRNSSecond Price Monitoring Extn
8th Oct 201812:02 pmRNSPrice Monitoring Extension
2nd Oct 20185:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSTrading Update
1st Oct 20184:51 pmRNSTotal Voting Rights
7th Sep 20184:35 pmRNSPrice Monitoring Extension
3rd Sep 20184:18 pmRNSDirector/PDMR Shareholding
3rd Sep 20188:58 amRNSHolding(s) in Company
23rd Aug 20184:19 pmRNSDirector/PDMR Shareholding
20th Aug 20181:41 pmRNSDirector/PDMR Shareholding
8th Aug 20184:00 pmRNSHolding(s) in Company
10th Jul 20184:52 pmRNSHolding(s) in Company
9th Jul 20183:32 pmRNSDirector/PDMR Shareholding
5th Jul 201812:11 pmRNSHolding(s) in Company
4th Jul 201812:08 pmRNSTotal Voting Rights
13th Jun 201810:14 amRNSDirector/PDMR Shareholding
11th Jun 20184:47 pmRNSHolding(s) in Company
8th Jun 20187:00 amRNSBlock Listing Application
5th Jun 201812:07 pmRNSBlock Listing Six Monthly Return - Replacement
4th Jun 20185:00 pmRNSHolding(s) in Company
4th Jun 201810:42 amRNSBlock Listing Six Monthly Return
1st Jun 201811:30 amRNSTotal Voting Rights
1st Jun 201811:24 amRNSHolding(s) in Company
31st May 20183:50 pmRNSCompletion of disposal
18th May 201811:13 amRNSDirector/PDMR Shareholding
11th May 20184:50 pmRNSDirector/PDMR Shareholding
8th May 20187:19 amRNSHalf-year Report
8th May 20187:15 amRNSDisposal
30th Apr 201812:20 pmRNSTotal Voting Rights and Capital
27th Apr 20184:39 pmRNSHolding(s) in Company
11th Apr 20183:56 pmRNSHolding(s) in Company
6th Apr 20181:31 pmRNSHolding(s) in Company
5th Apr 20187:00 amRNSTrading Update
26th Mar 20184:41 pmRNSDirector/PDMR Shareholding
26th Mar 20184:41 pmRNSDirector/PDMR Shareholding
5th Mar 20183:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.